ACRUX DDS PTY LTD
🏢 View company profile →25Patents
15Active
25Granted
45Portfolio score
Filing activity: Jul 24, 2001 → Nov 25, 2014 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6929801B2 | Transdermal delivery of antiparkinson agents | Human Necessities | 154 | Expired |
| US6818226B2 | Dermal penetration enhancers and drug delivery systems involving same | Emerging Cross-Sectional Technologies | 130 | Expired |
| US6923983B2 | Transdermal delivery of hormones | Human Necessities | 120 | Expired |
| US6978945B2 | Dispensing device | Human Necessities | 82 | Expired |
| US7387789B2 | Transdermal delivery of non-steroidal anti-inflammatory drugs | Emerging Cross-Sectional Technologies | 74 | Active |
| US8177449B2 | Spreading implement | Human Necessities | 63 | Active |
| US8435944B2 | Method and composition for transdermal drug delivery | Human Necessities | 35 | Active |
| US6916486B2 | Transdermal delivery of analgesics | Human Necessities | 34 | Expired |
| US8071075B2 | Dermal penetration enhancers and drug delivery systems involving the same | Emerging Cross-Sectional Technologies | 30 | Active |
| US7094422B2 | Topical delivery of antifungal agents | Human Necessities | 23 | Expired |
| US6916487B2 | Transdermal delivery of antiemetics | Human Necessities | 15 | Expired |
| US6998138B2 | Topical delivery of anti-alopecia agents | Human Necessities | 14 | Expired |
| USD749225S1 | Topical spreading applicator | General | 13 | Active |
| US6964777B2 | Transdermal delivery of antianxiety agents | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7438203B2 | Dermal penetration enhancers and drug delivery systems involving same | Emerging Cross-Sectional Technologies | 11 | Expired |
| USD750788S1 | Topical spreading applicator | General | 11 | Active |
| US8419307B2 | Spreading implement | Human Necessities | 8 | Active |
| US8357393B2 | Transdermal delivery rate control using amorphous pharmaceutical compositions | Human Necessities | 6 | Active |
| US9078810B2 | Transdermal delivery system | Human Necessities | 5 | Active |
| US9180194B2 | Method and composition for transdermal drug delivery | Human Necessities | 3 | Active |
| US9289586B2 | Spreading implement | Human Necessities | 3 | Active |
| US8807861B2 | Spreading implement | Human Necessities | 2 | Active |
| US10449343B2 | Device for dispensing and applying a liquid | Performing Operations; Transporting | 1 | Active |
| US8993520B2 | Method and composition for transdermal drug delivery | Human Necessities | 0 | Active |
| US8784878B2 | Transdermal delivery rate control using amorphous pharmaceutical compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.